Global Blood Type Testing Market Growth (Status and Outlook) 2025-2031

The global Blood Type Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Blood typing testing is a medical laboratory procedure used to determine an individual"s blood type or blood group. Blood typing is essential for various medical purposes, including blood transfusions, organ transplants, and prenatal care. There are several blood typing systems, but the most common and important one is the ABO blood group system and the Rh factor (RhD).

United States market for Blood Type Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Blood Type Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Blood Type Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Blood Type Testing players cover Bio-Rad Laboratories, QuidelOrtho, Grifols, S.A., Thermo Fisher Scientific, Immucor, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Blood Type Testing Industry Forecast” looks at past sales and reviews total world Blood Type Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Type Testing sales for 2025 through 2031. With Blood Type Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Type Testing industry.

This Insight Report provides a comprehensive analysis of the global Blood Type Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood Type Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Type Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Type Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Type Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Type Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Assay-based Techniques
PCR-based and Microarray Techniques
Massively Parallel Sequencing
Other

Segmentation by Application:
Hospitals
Blood Banks
Clinical Laboratories
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
QuidelOrtho
Grifols, S.A.
Thermo Fisher Scientific
Immucor
MosaiQ
Danaher
MERCK KGAA
BAG Diagnostics
Rapid Labs
Agena Bioscience
Biorex Diagnostics
Prestige Diagnostics
Dialab
Lorne Labs
Atlas Medical
Torax Biosciences
Fortress Diagnostics
AXO Science
Maxwin Health Care
JMitra & Co. Pvt. Ltd.
Medsource Ozone Biomedicals

Please note: The report will take approximately 2 business days to prepare and deliver.